Range
4.29 - 4.33
Vol / Avg.
13.5K/352.4K
Div / Yield
-
52 Wk
0.49 - 8.38
Mkt Cap
57.1M
Payout Ratio
-
Open
4.3
P/E
-
EPS
0.14
Shares
13.4M
Outstanding
13.4M
Total Float
13.4M
Benzinga - Mar 29, 2021, 4:06PM
load more
Sector: Health Care.Industry: Biotechnology
Biocept Inc develops and commercializes molecular diagnostic assays that provide physicians with clinically actionable information for treating and monitoring patients diagnosed with a variety of cancers. In addition to its portfolio of blood-based liquid biopsy assays, Biocept has developed the CNSide cerebrospinal fluid assay that detects cancer that has metastasized to the central nervous system. Biocept's patented Target Selector technology captures and quantitatively analyzes CSF tumor cells for tumor-associated molecular markers, using technology first developed for use in blood. It is also leveraging its molecular diagnostic capabilities to offer nationwide COVID-19 RT-PCR testing to support public health efforts during this unprecedented pandemic.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS0.190
REV13.670M17.756M4.086M
Q4 2020Est.ActualSurprise
EPS-0.2700.140 0.4100
REV12.320M18.511M6.191M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
BIOCBiocept-2.07%57.1M

Biocept Frequently Asked Questions

Q

How do I buy Biocept (BIOC) stock?

A

You can purchase shares of Biocept (NASDAQ: BIOC) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Biocept (BIOC) stock?

A

The latest price target for Biocept (NASDAQ: BIOC) was reported by Maxim Group on March 26, 2019. The analyst firm set a price target for 3.00 expecting BIOC to fall to within 12 months (a possible -29.58% downside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Biocept (BIOC)?

A

The stock price for Biocept (NASDAQ: BIOC) is $4.2601 last updated Today at 1:40:04 PM.

Q

Does Biocept (BIOC) pay a dividend?

A

There are no upcoming dividends for Biocept.

Q

When is Biocept (NASDAQ:BIOC) reporting earnings?

A
Biocept’s Q2 earnings are confirmed for after-market on August 11, 2021.
Q

Is Biocept (BIOC) going to split?

A

There is no upcoming split for Biocept.

Q

What sector and industry does Biocept (BIOC) operate in?

A

Biocept is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.